Emblica officinalis (Amla), a cornerstone of traditional Indian medicine, has gathered significant scientific attention for its diverse pharmacological properties and therapeutic potential. It is rich in ascorbic acid and a wide spectrum of bioactive phytochemicals such as polyphenols, flavonoids, tannins, and alkaloids. Amla exhibits potent antioxidant, anti-inflammatory, immunomodulatory, hepatoprotective, and antimicrobial effects. Contemporary research has increasingly validated its traditional uses and demonstrated its efficacy in managing a range of chronic and non-communicable diseases, including diabetes, cardiovascular disorders, dyslipidemia, cancer, and neurodegenerative conditions. Moreover, its adaptogenic and metabolic resilience-enhancing properties further underscore its value in preventive healthcare. This narrative review critically synthesises literature on the phytochemistry, pharmacological activities, and clinical relevance of E. officinalis, aiming to provide a comprehensive understanding of its mechanisms of action and therapeutic applications. The review also identifies existing research gaps and outlines directions for future investigation, positioning Amla as a promising candidate in the development of natural, safe, and effective therapeutic agents. Major Findings: Amla (Emblica officinalis) is a rich source of vitamin C, polyphenols, and tannins, exhibiting strong antioxidant, anti-inflammatory, and immunomodulatory effects. Preclinical and clinical studies support its benefits in managing lifestyle-related disorders such as dyslipidemia, diabetes, cardiovascular disease, and gastrointestinal and neurodegenerative conditions. Despite its therapeutic promise, wider use is limited by taste, awareness, and accessibility, highlighting the need for innovative formulations and large-scale clinical validation.
Patel et al. (Tue,) studied this question.